EXCELLOS, Inc
Excellos Labs is a cell therapy CDMO offering apheresis collection, PBMC and leukopak processing, T/NK cell isolation, and cGMP manufacturing for biotech and pharma.
Funding history
About EXCELLOS, Inc
How much funding has EXCELLOS, Inc raised?
EXCELLOS, Inc has raised $5.0M in total funding.
Where is EXCELLOS, Inc headquartered?
EXCELLOS, Inc is headquartered in San Diego, CA.
What does EXCELLOS, Inc do?
Excellos Labs is a cell therapy CDMO offering apheresis collection, PBMC and leukopak processing, T/NK cell isolation, and cGMP manufacturing for biotech and pharma.
What problem does EXCELLOS, Inc solve?
Cell therapy development is high-risk, and variability in donor cells and starting material can reduce the probability of clinical trial success.
What's EXCELLOS, Inc's solution?
Excellos Labs is a cell therapy CDMO that sources characterized donor material and provides cell isolation, process development, and cGMP manufacturing (from apheresis through commercial-scale production) for adoptive cell therapies like CAR-T, TIL, and TCR therapy.
What makes EXCELLOS, Inc different?
They cite a comprehensive per-donor immune/metabolic profiling platform, a consented and diverse high-retention donor pool enabling longitudinal data, cGMP ISO 7 cleanrooms across Miami and San Diego under one quality system, and backing/lab presence from OrganaBio, a company established in 1950.
What makes EXCELLOS, Inc notable?
Excellos was founded in 2021 as a spinout of the San Diego Blood Bank, and in 2026 its operating assets were acquired by OrganaBio to form a coast-to-coast cell therapy CDMO.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.